Technology
Health
Pharmaceutical
AcelRx Pharmaceuticals
$3.229876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.06 (1.90%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ACRX and other stocks, options, ETFs, and crypto commission-free!
About
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. Read More The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.
Employees
61
Headquarters
Redwood City, California
Founded
2005
Market Cap
248.88M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.94M
High Today
$3.30
Low Today
$3.07
Open Price
$3.21
Volume
857.65K
52 Week High
$5.05
52 Week Low
$1.99
Collections
Technology
Health
Pharmaceutical
US
North America
News
Seeking AlphaMar 21
AcelRx Pharmaceuticals (ACRX) Presents At Oppenheimer 29th Annual Healthcare Conference - Slideshow
The following slide deck was published by AcelRx Pharmaceuticals, Inc. in conjunction with this event. 1 45 Click to enlarge Notes:...
Yahoo FinanceMar 8
Here's Why Momentum Investors Will Love AcelRx Pharmaceuticals (ACRX)
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Wh...
Price Paid on Robinhood
4% Lower
Right Now
52 Week Low
$1.99
Average Price Paid
$3.35
52 Week High
$5.05
Earnings
-$0.29
-$0.25
-$0.22
-$0.18
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 8, After Hours